The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
Open accessAbstract
Mitochondrial dysfunction is a prominent feature of Alzheimer's disease (AD) neurons. In this study, we explored the involvement of an abnormal mitochondrial dynamics by investigating the changes in the expression of mitochondrial fission and fusion proteins in AD brain and the potential cause and consequence of these changes in neuronal cells. We found that mitochondria were redistributed away from axons in the pyramidal neurons of AD brain. Immunoblot analysis revealed that levels of DLP1 (also referred to as Drp1), OPA1, Mfn1, and Mfn2 were significantly reduced whereas levels of Fis1 were significantly increased in AD. Despite their differential effects on mitochondrial morphology, manipulations of these mitochondrial fission and fusion proteins in neuronal cells to mimic their expressional changes in AD caused a similar abnormal mitochondrial distribution pattern, such that mitochondrial density was reduced in the cell periphery of M17 cells or neuronal process of primary neurons and correlated with reduced spine density in the neurite. Interestingly, oligomeric amyloid-beta-derived diffusible ligands (ADDLs) caused mitochondrial fragmentation and reduced mitochondrial density in neuronal processes. More importantly, ADDL-induced synaptic change (i.e., loss of dendritic spine and postsynaptic density protein 95 puncta) correlated with abnormal mitochondrial distribution. DLP1 overexpression, likely through repopulation of neuronal processes with mitochondria, prevented ADDL-induced synaptic loss, suggesting that abnormal mitochondrial dynamics plays an important role in ADDL-induced synaptic abnormalities. Based on these findings, we suggest that an altered balance in mitochondrial fission and fusion is likely an important mechanism leading to mitochondrial and neuronal dysfunction in AD brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased accumulation of APP and its processed peptides in the mitochondria of AD neurons and their effects on mitochondrial dynamics and mitophagy have been documented (21–24).”
From Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity (2025) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mitochondrial fission-fusion dynamics through alterations of Drp1, Parkin, and Pink1 functions (23,24), which play essential roles in mitophagy induction and mitochondrial quality control during healthy brain aging, are disrupted in various neurodegenerative diseases, including Parkinson’s disease (PD) and AD (25).”
From Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity (2025) · cites this paper as [24]
In the citing paper
“Aβ accumulates in mitochondria in AD brain, which is accompanied by altered mitochondrial structure, decreased mitochondrial respiratory function and ATP production, impaired mitochondrial dynamics, and elevated mitochondria-associated oxidative stress.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [97]
In the citing paper
“Mitochondrial Aβ levels correlate with abnormalities in mitochondrial structure and function.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [97]
In the citing paper
“Aβ peptides can induce ROS production from mitochondria, leading to release of cytochrome c and apoptosis-inducing factor, thereby driving mitochondrial dysfunction, cell apoptosis and neuronal loss [97, 100].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [97]
In the citing paper
“Soluble Aβ oligomers disrupted the balance between mitochondrial fission and fusion, leading to significant mitochondrial dysfunction.197,198”
From Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future (2023) · cites this paper as [197]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Dynamin-related Protein Drp1 Is Required for Mitochondrial Division in Mammalian Cells
Smirnova, E., Griparić, L., Shurland, D., & van der Bliek, A. M. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.8.2245 · Cited by 1,938
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2004) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,722
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses
Li, Z., Okamoto, K.-I., Hayashi, Y., & Sheng, M. (2004) · Cell · doi:10.1016/j.cell.2004.11.003 · Cited by 1,498
Cited by
Sorted by citations
Items 201–300 of 1,001
Linking Oxidative Stress and Proteinopathy in Alzheimer’s Disease
Sharma, C., & Kim, S. R. (2021) · Antioxidants · doi:10.3390/antiox10081231 · Cited by 145
Cuadrado‐Tejedor, M., Vilariño, M., Cabodevilla, F., Río, J. D., Frechilla, D., & Pérez‐Mediavilla, A. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100966 · Cited by 134
Silva, D. F., Selfridge, J. E., Lu, J., E, L., Roy, N., Hutfles, L., Burns, J. M., Michaelis, E. K., Yan, S., Cardoso, S. M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt247 · Cited by 133
Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid
Yao, J., Irwin, R. W., Chen, S., Hamilton, R., Cadenas, E., & Brinton, R. D. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.001 · Cited by 133
Rosenfeld, M., Brenner-Lavie, H., Gal-Ben-Ari, S., Kavushansky, A., & Ben‐Shachar, D. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.010 · Cited by 132
Nakamura, T., Cieplak, P., Cho, D., Godzik, A., & Lipton, S. A. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.04.007 · Cited by 138
Corsetti, V., Florenzano, F., Atlante, A., Bobba, A., Ciotti, M. T., Natale, F., Della Valle, F., Borreca, A., Manca, A., Meli, G., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv059 · Cited by 129
Oettinghaus, B., Schulz, J. M., Restelli, L. M., Licci, M., Savoia, C., Schmidt, A., Schmitt, K., Grimm, A., Morè, L., Hench, J., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.39 · Cited by 130
Axonal Endoplasmic Reticulum Dynamics and Its Roles in Neurodegeneration
Öztürk, Z., O’Kane, C. J., & Pérez-Moreno, J. J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00048 · Cited by 136
Rehman, M. U., Sehar, N., Dar, N. J., Khan, A., Arafah, A., Rashid, S., Rashid, S. M., & Ganaie, M. A. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104961 · Cited by 130
Eckert, A., Nisbet, R. M., Grimm, A., & Götz, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.013 · Cited by 133
Abnormal Mitochondrial Dynamics in the Pathogenesis of Alzheimer's Disease
Zhu, X., Perry, G., Smith, M. A., & Wang, X. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129005 · Cited by 242
Self-citationWang, X., Su, B., Liu, W., He, X., Gao, Y., Castellani, R. J., Perry, G. L., Smith, M. A., & Zhu, X. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00721.x · Cited by 134
Self-citationNeuronal Mitochondria Modulation of LPS-Induced Neuroinflammation
Harland, M., Torres, S. L., Liu, J., & Wang, X. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2324-19.2020 · Cited by 131
Self-citationYu, L., Wang, S., Chen, X., Yang, H., Li, X., Xu, Y., & Zhu, X. (2015) · Life Sciences · doi:10.1016/j.lfs.2014.11.021 · Cited by 127
Self-citationMitochondrial Ca2+ and neurodegeneration
Calí, T., Ottolini, D., & Brini, M. (2012) · Cell Calcium · doi:10.1016/j.ceca.2012.04.015 · Cited by 132
Mitochondrial Dysfunction—A Pharmacological Target in Alzheimer's Disease
Eckert, G. P., Renner, K., Eckert, S. H., Eckmann, J., Hagl, S., Abdel-Kader, R. M., Kurz, C., Leuner, K., & Muller, W. E. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8271-z · Cited by 127
Amyloid-β-Derived Diffusible Ligands Cause Impaired Axonal Transport of Mitochondria in Neurons
Wang, X., Perry, G. L., Smith, M. A., & Zhu, X. (2010) · Neurodegenerative Diseases · doi:10.1159/000283484 · Cited by 126
Self-citationLiu, W., & Zhou, C. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.12.003 · Cited by 129
Mitochondrial Dysfunction in Neural Injury
Zhao, X., Lu, M., Yuan, D., Xu, D.-E., Yao, P.-P., Ji, W., Chen, H., Liu, W., Yan, C.-X., Xia, Y., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00030 · Cited by 132
Cholesterol impairs autophagy-mediated clearance of amyloid beta while promoting its secretion
Barbero-Camps, E., Roca-Agujetas, V., Bartolessis, I., de Dios, C., Fernández-Checa, J. C., Marí, M., Morales, A., Hartmann, T., & Colell, A. (2018) · Autophagy · doi:10.1080/15548627.2018.1438807 · Cited by 125
Yan, J., Liu, X.-H., Han, M., Wang, Y., Sun, X., Yu, N., Li, T., Su, B., & Chen, Z.-Y. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.08.005 · Cited by 126
Self-citationHaun, F., Nakamura, T., Shiu, A. D., Cho, D.-H., Tsunemi, T., Holland, E. A., Spada, A. R. L., & Lipton, S. A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4928 · Cited by 129
Cho, B., Choi, S. Y., Cho, H. M., Kim, H. J., & Sun, W. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.3.149 · Cited by 129
A Mitocentric View of Alzheimer's Disease Suggests Multi-Faceted Treatments
Gibson, G. E., & Shi, Q. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100336 · Cited by 124
Connecting the dots between tau dysfunction and neurodegeneration
Frost, B., Götz, J., & Feany, M. B. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.07.005 · Cited by 124
Mitochondrial dysfunction and Alzheimer's disease
Maruszak, A., & Żekanowski, C. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.004 · Cited by 124
Grel, H., Woźnica, D., Ratajczak, K., Kalwarczyk, E., Anchimowicz, J., Świtlik, W. Z., Olejnik, P., Zielonka, P., Stobiecka, M., & Jakieła, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713033 · Cited by 140
Oxidative Stress and Mitochondrial Dysfunction in Down Syndrome
Pagano, G., & Castello, G. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_22 · Cited by 125
Kim, K., Perkins, G. A., Shim, M. S., Bushong, E., Alcasid, N. J., Ju, S., Ellisman, M. H., Weinreb, R. N., & Ju, W.-K. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.180 · Cited by 122
Effects of Polyphenols on Brain Ageing and Alzheimer’s Disease: Focus on Mitochondria
Schaffer, S., Asseburg, H., Kuntz, S., Muller, W. E., & Eckert, G. P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8282-9 · Cited by 124
Mitochondrial Biology and Neurological Diseases
Arun, S., Liu, L., & Dönmez, G. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150703154541 · Cited by 123
Alzheimer's disease: diverse aspects of mitochondrial malfunctioning.
Santos, R. X., Correia, S. C., Wang, X., Perry, G. L., Smith, M. A., Moreira, P. I., & Zhu, X. (2010) · Europe PMC (PubMed Central) · Cited by 120
Self-citationInsulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer‘s Disease
Nuzzo, D., Picone, P., Baldassano, S., Caruana, L., Messina, E., Gammazza, A., Cappello, F., Mulè, F., & Carlo, M. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150710115506 · Cited by 119
The dynamin GTPase OPA1: More than mitochondria?
Belenguer, P., & Pellegrini, L. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.08.004 · Cited by 125
New Insights in the Amyloid-Beta Interaction with Mitochondria
Spuch, C., Ortolano, S., & Fernández-Balbuena, C. N. (2012) · Journal of Aging Research · doi:10.1155/2012/324968 · Cited by 121
Deconstructing Mitochondrial Dysfunction in Alzheimer Disease
García‐Escudero, V., Martín-Maestro, P., Perry, G. L., & Ávila, J. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/162152 · Cited by 120
Self-citationIhenacho, U. K., Nolden, K. A., Harwig, M. C., Widlansky, M. E., & Hill, R. B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.660095 · Cited by 117
Iijima‐Ando, K., Hearn, S., Shenton, C., Gatt, A., Zhao, L., & Iijima, K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008310 · Cited by 126
TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration
Gao, J., Wang, L., Yan, T., Perry, G. L., & Wang, X. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.103396 · Cited by 124
Self-citationKang, T. (2020) · Antioxidants · doi:10.3390/antiox9070617 · Cited by 120
Cereghetti, G. M., Costa, V., & Scorrano, L. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.61 · Cited by 121
Reddy, P. H., Manczak, M., & Yin, X. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170051 · Cited by 116
Are there roles for brain cell senescence in aging and neurodegenerative disorders?
Tan, F. C. C., Hutchison, E. R., Eitan, E., & Mattson, M. P. (2014) · Biogerontology · doi:10.1007/s10522-014-9532-1 · Cited by 116
Effect of ApoE isoforms on mitochondria in Alzheimer disease
Yin, J., Reiman, E. M., Beach, T. G., Serrano, G. E., Sabbagh, M. N., Nielsen, M., Caselli, R. J., & Shi, J. (2020) · Neurology · doi:10.1212/wnl.0000000000009582 · Cited by 116
Cellular prion protein is essential for oligomeric amyloid- -induced neuronal cell death
Kudo, W., Hp, L., Zou, W.-Q., Wang, X., Perry, G., Zhu, X., Smith, M. A., Petersen, R. B., & Lee, H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr542 · Cited by 116
Self-citationPosttranslational modifications of α-tubulin in alzheimer disease
Zhang, F., Su, B., Wang, C., Siedlak, S. L., Mondragón‐Rodríguez, S., Lee, H., Wang, X., Perry, G. L., & Zhu, X. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0030-4 · Cited by 116
Self-citationNakamura, T., Cho, D., & Lipton, S. A. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.032 · Cited by 114
Neuronal failure in Alzheimer’s disease: a view through the oxidative stress looking-glass
Bonda, D., Wang, X., Lee, H., Smith, M. A., Perry, G. L., & Zhu, X. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1424-x · Cited by 114
Self-citationCalcium-Handling Defects and Neurodegenerative DiseasePreprint
Schrank, S., Barrington, N. M., & Stutzmann, G. E. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a035212 · Cited by 115
Deceleration of Fusion–Fission Cycles Improves Mitochondrial Quality Control during Aging
Figge, M. T., Reichert, A. S., Meyer‐Hermann, M., & Osiewacz, H. D. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002576 · Cited by 114
OPA1 loss of function affects in vitro neuronal maturation
Bertholet, A. M., Millet, A. M. C., Guillermin, O., Daloyau, M., Davezac, N., Miquel, M., & Belenguer, P. (2013) · Brain · doi:10.1093/brain/awt060 · Cited by 110
Lee, A., Kondapalli, C., Virga, D. M., Lewis, T. L., Koo, S. Y., Ashok, A., Mairet‐Coello, G., Herzig, S., Foretz, M., Viollet, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32130-5 · Cited by 119
Shields, L. Y., Kim, H., Zhu, L., Haddad, D., Berthet, A., Pathak, D., Lam, M., Ponnusamy, R., Diaz‐Ramirez, L. G., Gill, T. M., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.94 · Cited by 113
Agujetas, V. R., Barbero‐Camps, E., de Dios, C., Podlesniy, P., Abadin, X., Morales, A., Marı́, M., Trullás, R., & Colell, A. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00435-6 · Cited by 113
Mitochondria-derived peptides in aging and healthspan
Miller, B., Kim, S.-J., Kumagai, H., Yen, K., & Cohen, P. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158449 · Cited by 121
Markham, A., Bains, R. S., Franklin, P., & Spedding, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12531 · Cited by 113
Mitochondria Dysfunction and Neurodegenerative Disorders: Cause or Consequence
Morais, V. A., & Strooper, B. D. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100345 · Cited by 111
Impaired quality control of mitochondria: Aging from a new perspective
Weber, T. A., & Reichert, A. S. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.03.018 · Cited by 112
Are Tangles as Toxic as They Look?
Spires-Jones, T. L., Kopeikina, K. J., Koffie, R. M., de Calignon, A., & Hyman, B. T. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9566-7 · Cited by 104
Silva, D. F., Esteves, A. R., Oliveira, C. R., & Cardoso, S. M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9951-x · Cited by 110
Zyśk, M., Beretta, C., Naia, L., Dakhel, A., Påvénius, L., Brismar, H., Lindskog, M., Ankarcrona, M., & Erlandsson, A. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02722-z · Cited by 115
Mitochondrial Fusion Proteins and Human Diseases
Ranieri, M., Brajkovic, S., Riboldi, G. M., Ronchi, D., Rizzo, F., Bresolin, N., Corti, S. P., & Comi, G. P. (2013) · Neurology Research International · doi:10.1155/2013/293893 · Cited by 116
The Impact of Mitochondrial Fusion and Fission Modulation in Sporadic Parkinson’s Disease
Santos, D., Esteves, A. R., Silva, D. F., Januário, C., & Cardoso, S. M. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8893-4 · Cited by 117
Galea, E., Launay, N., Portero-Otin, M., Ruiz, M., Pamplona, R., Aubourg, P., Ferrer, I., & Pujol, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.005 · Cited by 108
Pallardó, F. V., Lloret, A., Lebel, M., d’Ischia, M., Cogger, V. C., Couteur, D. G. L., Gadaleta, M. N., Castello, G., & Pagano, G. (2010) · Biogerontology · doi:10.1007/s10522-010-9269-4 · Cited by 107
Nakamura, T., & Lipton, S. A. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0476-x · Cited by 108
Alzheimer, mitochondria and gender
Grimm, A., Mensah‐Nyagan, A. G., & Eckert, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.012 · Cited by 111
Zádori, D., Veres, G., Szalárdy, L., Klivènyi, P., & Vécsei, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170929 · Cited by 108
Wang, Z., Wang, C., Yuan, B., Liu, L., Zhang, H., Zhu, M., Chai, H., Peng, J., Huang, Y. H., Zhou, S., et al. (2025) · Microbiome · doi:10.1186/s40168-024-02001-w · Cited by 125
Hyperinsulinemia Induces Insulin Resistance in Dorsal Root Ganglion Neurons
Kim, B., McLean, L. L., Philip, S., & Feldman, E. L. (2011) · Endocrinology · doi:10.1210/en.2011-0029 · Cited by 113
Physical Exercise and Brain Mitochondrial Fitness: The Possible Role Against Alzheimer's Disease
Bernardo, T. C., Marques‐Aleixo, I., Beleza, J., Oliveira, P. J., Ascensão, A., & Magalhães, J. (2016) · Brain Pathology · doi:10.1111/bpa.12403 · Cited by 108
Peng, Y., Gao, P., Shi, L., Chen, L., Liu, J., & Long, J. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7763 · Cited by 110
Insights into Disease-Associated Tau Impact on Mitochondria
Szabo, L., Eckert, A., & Grimm, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176344 · Cited by 107
Salminen, A., Haapasalo, A., Kauppinen, A., Kaarniranta, K., Soininen, H. S., & Hiltunen, M. O. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.001 · Cited by 107
Staff, N. P., Podratz, J. L., Grassner, L., Lange, M. L. B., Paz, J., Knight, A. M., Loprinzi, C. L., Trushina, E. V., & Windebank, A. J. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.09.001 · Cited by 103
Reddy, P. H. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.03.020 · Cited by 109
Du, F., Yan, S., Yu, Q., Chen, D., & Yan, S. S. (2016) · Scientific Reports · doi:10.1038/srep31462 · Cited by 109
Interaction of misfolded proteins and mitochondria in neurodegenerative disorders
Abramov, A. Y., Berezhnov, A. V., Fedotova, E. I., Зинченко, В. П., & Долгачева, Л. П. (2017) · Biochemical Society Transactions · doi:10.1042/bst20170024 · Cited by 109
Jiang, S., Nandy, P., Wang, W., Ma, X., Hsia, J., Wang, C., Wang, Z., Niu, M., Siedlak, S. L., Torres, S. L., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0238-8 · Cited by 104
Self-citationRetinal ganglion cell dendritic degeneration in a mouse model of Alzheimer's disease
Williams, P. A., Thirgood, R. A., Oliphant, H., Frizzati, A., Littlewood, E., Votruba, M., Good, M. A., Williams, J. H., & Morgan, J. E. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.006 · Cited by 105
Nakamura, T., & Lipton, S. A. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3570 · Cited by 104
MFN2 couples glutamate excitotoxicity and mitochondrial dysfunction in motor neurons
Wang, W., Zhang, F., Li, L., Tang, F., Siedlak, S. L., Fujioka, H., Liu, Y., Su, B., Pi, Y., & Wang, X. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.617167 · Cited by 103
Self-citationMelatonin and mitochondrial dysfunction in the central nervous system
Cardinali, D. P., Pagano, E. S., Bernasconi, P. A. S., Reynoso, R., & Scacchi, P. A. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.02.020 · Cited by 103
Hoekstra, J. G., Hipp, M. J., Montine, T. J., & Kennedy, S. R. (2016) · Annals of Neurology · doi:10.1002/ana.24709 · Cited by 108
Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?
Peggion, C., Calí, T., & Brini, M. (2024) · Antioxidants · doi:10.3390/antiox13020240 · Cited by 112
Pathogenesis and Disease-modifying Therapy in Alzheimer's Disease: The Flat Line of Progress
Castellani, R. J., & Perry, G. L. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.09.009 · Cited by 104
Self-citationFields, J. A., Serger, E., Campos, S., Divakaruni, A. S., Kim, C., Smith, K., Trejo, M., Adame, A., Spencer, B. J., Rockenstein, E. M., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.11.015 · Cited by 102
Calvo-Rodríguez, M., Hernando-Pérez, E., Núñez, L., & Villalobos, C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00022 · Cited by 103
Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model
Zhou, Y., Carmona, S., Muhammad, A. K. M. G., Bell, S., Landeros, J., Vazquez, M., Ho, R., Franco, A., Lü, B., Dorn, G. W., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124194 · Cited by 102
Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis
Weidling, I. W., & Swerdlow, R. H. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113321 · Cited by 104
The social nature of mitochondria: Implications for human health
Picard, M. A., & Sandi, C. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.017 · Cited by 107
Mitochondria, Cybrids, Aging, and Alzheimer's Disease
Swerdlow, R. H., Koppel, S., Weidling, I., Hayley, C., Ji, Y., & Wilkins, H. M. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2016.12.017 · Cited by 106
Lackner, L. L., & Nunnari, J. M. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.05.016 · Cited by 101
Mitochondrial division: molecular machinery and physiological functions
Kageyama, Y., Zhang, Z., & Sesaki, H. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.04.009 · Cited by 101
Chiu, K., Chan, T. F., Wu, A., Leung, I. Y.-P., So, K., & Chang, R. C. (2011) · AGE · doi:10.1007/s11357-011-9260-2 · Cited by 100
Li, X., & Buxbaum, J. N. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-79 · Cited by 104
Self-citationShahni, R., Cale, C. M., Anderson, G. W., Osellame, L. D., Hambleton, S., Jacques, T. S., Wedatilake, Y., Taanman, J., Chan, E., Qasim, W., et al. (2015) · Brain · doi:10.1093/brain/awv182 · Cited by 102
Synaptic plasticity in Alzheimer’s disease and healthy aging
Torres, D. M. C., & Cárdenas, F. P. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0058 · Cited by 101
Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort
Lakatos, A., Derbeneva, O. A., Younes, D., Keator, D. B., Bakken, T. E., Lvova, M., Brandon, M. C., Guffanti, G., Reglődi, D., Saykin, A. J., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.031 · Cited by 97
Metadata
- Authors
- Wang, X., Su, B., Lee, H.-G., Li, X., Perry, G., Smith, M. A., & Zhu, X.
- Affiliations
- Case Western Reserve University (US)
- The University of Texas at San Antonio (US)
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-07-15
- Volume
- 29
- Issue
- 28
- Pages
- 9090-9103
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC2735241
- OpenAlex
- W2089141103
- Cited by
- 1,224
- References
- 50
- Citations by year
- 2026: 49 · 2025: 82 · 2024: 71 · 2023: 92 · 2022: 77 · 2021: 102 · 2020: 83 · 2019: 71 · 2018: 60 · 2017: 75 · 2016: 67 · 2015: 59 · 2014: 57 · 2013: 58 · 2012: 84
- FWCI
- 29.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association (AG031852, IIRG-07-60196)
- National Institutes of Health (IIRG-07-60196)
- National Institute on Aging (AG 031852, R01AG031852)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- Alzheimer's disease, mitochondrial dynamics, mitochondrial fission, mitochondrial fusion, Drp1, OPA1, Mfn1, mitofusin 2, Fis1, mitochondrial distribution, axons, pyramidal neurons, synaptic loss, dendritic spines, PSD-95, mitochondrial dysfunction
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Animals, Antibodies, Monoclonal, Biotin, Cells, Cultured, Embryo, Mammalian, Gene Expression Regulation, Hippocampus, Humans, Membrane Proteins, Microtubule-Associated Proteins, Middle Aged, Mitochondria, Mutation, Neuroblastoma, Neurons, Postmortem Changes, Time Factors, Transfection, Amyloid beta-Peptides, Microscopy, Immunoelectron, Reactive Oxygen Species, GTP Phosphohydrolases, Mitochondrial Proteins, Membrane Transport Proteins, Mitochondrial Membrane Transport Proteins, Dynamins, Green Fluorescent Proteins, Rats, Cyclooxygenase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
